Physiopathological role of selenium and selenoprotein in neuropsychiatry disease

Journal of Medical Sciences

Volumn 11, Issue 1, 2011, Pages 11-18

  Ozdemir, Ercan ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antioxidant; Brain functions; Glutathione peroxidase; Selenium; Selenoprotein

Indexed keywords

APOLIPOPROTEIN E; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE PEROXIDASE 3; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SELENIUM; SELENIUM BINDING PROTEIN; SELENIUM BINDING PROTEIN 1; SELENOPROTEIN; SELENOPROTEIN N; SELENOPROTEIN P; SELENOPROTEIN W; THIOREDOXIN REDUCTASE; THYROXINE DEIODINASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BIPOLAR DISORDER; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN TUMOR; CELL LOSS; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEPRESSION; ENZYME INACTIVATION; EPILEPSY; HUMAN; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEURONAL CEROID LIPOFUSCINOSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SCHIZOPHRENIA; SEIZURE; VITAMIN SUPPLEMENTATION;

EID: 79959435178     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2011.11.18     Document Type: Review

References (57)

1. Akesson, B., T. Bellew and R.F. Burk, 1994. Purification of selenoprotein P from human plasma. Biochim. Biophys. Acta, 1204: 243-249.
2. Angelova, E.A., P.A. Atanassova, N.T. Chalakova and B.D. Dimitrov, 2008. Associations between serum selenium and total plasma homocysteine during the acute phase of ischaemic stroke. Eur. Neurol., 60: 298-303.
3. Arner, E.S. and A. Holmgren, 2000. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem., 267: 6102-6109.
4. Atif, F., S. Yousuf and S.K. Agrawal, 2008. Restraint stress-induced oxidative damage and its amelioration with selenium. Eur. J. Pharmacol., 600: 59-63.
5. Basun, H., L.G. Forssell, L. Wetterberg and B. Winblad, 1991. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J. Neural Transm. Park Dis. Dement. Sect., 3: 231-258.
6. Behne, D., H. Hilmert, S. Scheid, H. Gessner and W. Elger, 1988. Evidence for specific selenocysteine target tissues and new biologically important selenoproteins. Biochem. Biophys. Acta, 966: 12-21.
7. Beilstein, M.A., S.C. Vendeland, E. Barofsky, O.N. Jensen and P.D. Whanger, 1996. Selenoprotein W of rat muscle binds glutathione and an unknown small molecular weight moiety. J. Inorg. Biochem., 61: 117-124.
8. Benton, D. and R. Cook, 1991. The impact of selenium supplementation on mood. Biol-Psychiatry, 29: 1092-1098.
9. Benton, D., 2002. Selenium intake, mood and other aspects of psychological functioning. Nutr. Neurosci., 5: 363-374.
10. Burk, R.F. and K.E. Hill, 1994. Selenoprotein P: A selenium-rich extracellular glycoprotein. J. Nutr., 124: 1891-1897.
11. Burk, R.F., K.E. Hill, G.E. Olson, E.J. Weeber, A.K. Motley, V.P. Winfrey and L.M. Austin, 2007. Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed. J. Neurosci., 27: 6207-6211.
12. Castellano, S., N. Morozova, M. Morey, M.J. Berry, F. Serras, M. Corominas and R. Guigo, 2001. In silico identification of novel selenoproteins in the Drosophila melanogaster genome. EMBO Rep., 2: 697-702.
13. Chen, M.L. and C.H. Chen, 2005. Microarray analysis of differentially expressed genes in rat frontal cortex under chronic risperidone treatment. Neuropsychopharmacology, 30: 268-277.
14. Clausen, J., G.E. Jensen and S. A. Nielsen, 1988. Selenium in chronic neurological diseases, multiple sclerosis and Batten's disease. Biol. Trace Elem. Res., 15: 179-203.
15. Cornett, C.R., W.R Markesbery and W.D. Ehmann, 1998. Imbalances of trace elements related to oxidative damage in Alzheimers disease brain. Neurotoxicity, 19: 339-346.
16. Crack, P.J., J.M. Taylor, J.B. de Haan, I. Kola, P. Hertzog and R.C. Iannello, 2003. Glutathione peroxidase-1 contributes to the neuroprotection seen in the superoxide dismutase-1 transgenic mouse in response to ischemia/reperfusion injury. J. Cereb. Blood Flow Metab., 23: 19-22.
17. De Haan, J.B., C. Bladier, P. Griffiths, M. Kelner and R.D. O'Shea et al, 1998. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpxl, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J. Biol. Chem., 273: 22528-22536.
18. Dexter, D.T., C.J. Carter, F.R. Wells, F. Javoy-Agid and Y. Agid et at, 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem., 52: 381-389.
19. Drasch, G., S. Mailander, C. Schlosser and G. Roider, 2000. Content of non-mercury-associated selenium in human tissues. Biol. Trace Elem. Res., 77: 219-230.
20. Dreher, I., C. Schmutzler, F. Jakob and J. Kohrle, 1997. Expression of selenoproteins in various rat and human tissues and cell lines. J. Trace Elem. Med. Biol, 11: 83-91.
21. Dringen, R., L. Kussmaul, J.M. Gutterer, J. Hirrlinger and B. Hamprecht, 1999. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J. Neurochem., 72: 2523-2530.
22. Drukarch, B., E. Schepens, J.C. Stoof, C.H. Langeveld and F.L. van Muiswinkel, 1998. Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species. Free Radic. Biol. Med., 25: 217-220.
23. Ejima, A., C. Watanabe, H. Koyama, K. Matsuno and H. Satoh, 1996. Determination of selenium in the human brain by graphite furnace atomic absorption spectrometry. Biol. Trace Elem. Res., 54: 9-21.
24. Ely, J.T.A., 2001. Mercury induced Alzheimer's disease: Accelerating incidence?. Bull. Environ. Contain. Toxicol., 67: 800-806.
25. Fomenko, D.E., W. Xing, B.M. Adair, D.J. Thomas and V.N. Gladyshev, 2007. High-throughput identification of catalytic redox-active cysteine residues. Science, 315: 387-389.
26. Gu, Q.P., M.A. Beilstein, E. Barofsky, W. Ream and P.D. Whanger, 1999. Purification, characterization and glutathione binding to selenoprotein W from monkey muscle. Arch. Biochem. Biophys., 361: 25-33.
27. Halliwell, B., 1992. Reactive oxygen species and the central nervous system. J. Neurochem., 5: 1609-1623.
28. Harrison, P.J., 2002. The neuropathology of primary mood disorder. Brain, 125: 1428-1449.
29. Hill, K.E., J. Zhou, W.J. McMahan, A.K. Motley, J.F. Atkins, R.F. Gesteland and R.F. Burk, 2003. Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol. Chem., 278: 13640-13646.
30. Hill, K.E., J. Zhou, W.J. McMahan, A.K. Motley and R.F. Burk, 2004. Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J.Nutr., 134: 157-161.
31. Hill, K.E., J. Zhou, L.M. Austin, A.K. Motley and A.J.L. Hamx et al, 2007. The selenium-richC-terminal domain of mouse selenoprotein P is necessary for the supply of selenium to brain and testis but not for the maintenance of whole body selenium. J. Biol. Chem., 282: 10972-10980.
32. Ho, Y.S., J.L. Magnenat, R.T. Bronsoni, J. Cao, M. Gargano, M. Sugawara and CD. Funk, 1997. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J. Biol. Chem., 272: 16644-16651.
33. Jonnalagadda, S.B. and P.V. Rao, 1993. Toxicity, bioavailability and metal speciation. Comp. Biochem. Physiol. C, 106: 585-595.
34. Kanazawa, T., G. Chana, S.J. Glatt, H. Mizuno and E. Masliah et al 2008. The utility of SELENBPl gene expression as a biomarker for major psychotic disorders: Replication in schizophrenia and extension to bipolar disorder with psychosis. Am. J. Med. Genet. BNeuropsychiatr. Genet., 147: 686-689.
35. Kryukov, G.V., S. Castellano, S.V. Novoselov, A.V. Lobanov, O. Zehtab, R. Guigo and V.N. Gladyshev, 2003. Characterization of mammalian selenoproteomes. Science, 300: 1439-1443.
36. Kumaraswamy, E., A. Malykh, K.V. Korotkov, S. Kozyavkin, Y. Hu and S.Y. Kwon et al., 2000. Structure-Expression relationships of the 15-kDa selenoprotein gene: Possible role of the protein in cancer etiology. J. Biol. Chem., 275: 35540-35547.
37. Kutluhan, S., M. Naziroglu, O. Celik and M. Yilmaz, 2009. Effects of selenium and topiramate on lipid peroxidation and antioxidant vitamin levels in blood of pentylentetrazol-induced epileptic rats. Biol. Trace Elmen. Res., 129: 181-189.
38. Low, S.C. and M.J. Berry, 1996. Knowing when not to stop: Selenocysteine incorporation in eukaryotes. Trends Biochem. Sci., 21: 203-208.
39. Miyaguchi, K., 2004. Localization of selenium-binding protein at the tips of rapidly extending protrusions. Histochem. Cell Biol, 121: 371-376.
40. Moghadaszadeh, B. and A.H. Beggs, 2006. Selenoproteins and their impact on human health through diverse physiological pathways. Physiology, 21: 307-315.
41. Mushak, P., 1985. Potential impact of acid precipitation on arsenic and selenium. Environ. Health Perspect, 63: 105-113.
42. Ozdemir, E., S. Cetinkaya, S. Ersan, S. Kucukosman and E.E. Ersan, 2009. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 33: 62-65.
43. Papp, L.V., J. Lu, A. Holmgren and K.K. Khanna, 2007. From selenium to selenoproteins: Synthesis, identity and their role in human health. Antioxidant Redox Signaling, 9: 775-806.
44. Pappas, A.C., E. Zoidis, P.F. Sural and G. Zervas, 2008. Selenoproteins and maternal nutrition. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 151: 361-372.
45. Peters, M.M., K.E. Hill, R.F. Burk and E.J. Weeber, 2006. Altered hippocampus synaptic function in selenoprotein P deficient mice. Mol. Neurodegener., 1: 12-12.
46. Philipov, P. and K. Tzatchev, 1988. Selenium concentrations in serum of patients with cerebral and extracerebral tumors. Zentralbl. Nuerochir., 49: 344-347.
47. Ragusa, R.J., C.K. Chow and J.D. Porter, 1997. Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul. Disord., 7: 379-386.
48. Ramaekers, V.T., M. Calomme, D. Vanden Berghe and W. Makropoulos, 1994. Selenium deficiency triggering intractable seizures. Neuropediatrics, 25: 217-223.
49. Rayman, M.P., 2000. The importance of selenium to human health. Lancet, 356: 233-241.
50. Rhee, S.G., H.Z. Chae, K. Kim, 2005. Peroxiredoxms: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med., 38: 1543-1552.
51. Schomburg, L., U. Schweizer and J. Kohrle, 2004. Selenium and selenoproteins in mammals: Extraordinary, essential, enigmatic. Cell Mol. Life Sci., 61: 1988-1995.
52. Schweizer, U., F. Streckfuss, P. Pelt, B.A. Carlson, L. Hatfield, J. Kohrle and L. Schomburg, 2005. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem. J., 386: 221-226.
53. Sher, L., 2008. Depression and suicidal behavior in alcohol abusing adolescents: Possible role of selenium deficiency. Minerva Pediatr., 60: 201-209.
54. Smith, CD., J.M. Carney, P.E. Starke Reed, C.N. Oliver, R. Stadtman, R.A. Floyd and W.R. Markesbery, 1991. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA., 88: 10540-10543.
55. Wenstrup, D., W.D. Ehmannand, W.R. Markesbery, 1990. Trace element imbalance in isolated subcelluar fractions of Alzheimer's disease brains. Brain Res., 533: 125-131.
56. Whanger, P.D., 2001. Selenium and the brain: A review. Nutr. Neurosci., 4: 81-97.
57. Whanger, P.D., 2002. Selenocompounds in plants and animals and their biological significance. J. Am. College Nutr., 21: 223-232.